BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15131048)

  • 1. The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells.
    Naume B; Wiedswang G; Borgen E; Kvalheim G; Kåresen R; Qvist H; Janbu J; Harbitz T; Nesland JM
    Clin Cancer Res; 2004 May; 10(9):3091-7. PubMed ID: 15131048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome.
    Synnestvedt M; Borgen E; Schlichting E; Schirmer CB; Renolen A; Giercksky KE; Nesland JM; Naume B
    Breast Cancer Res Treat; 2013 Apr; 138(2):485-97. PubMed ID: 23456230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.
    Naume B; Borgen E; Kvalheim G; Kåresen R; Qvist H; Sauer T; Kumar T; Nesland JM
    Clin Cancer Res; 2001 Dec; 7(12):4122-9. PubMed ID: 11751511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed.
    Wiedswang G; Borgen E; Karesen R; Naume B
    Cytotherapy; 2003; 5(1):40-5. PubMed ID: 12745581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.
    Wiedswang G; Borgen E; Kåresen R; Qvist H; Janbu J; Kvalheim G; Nesland JM; Naume B
    Clin Cancer Res; 2004 Aug; 10(16):5342-8. PubMed ID: 15328170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
    Janni W; Rack B; Schindlbeck C; Strobl B; Rjosk D; Braun S; Sommer H; Pantel K; Gerber B; Friese K
    Cancer; 2005 Mar; 103(5):884-91. PubMed ID: 15666325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
    Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
    J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis between the HER2 status in primary breast cancer tissue and the detection of isolated tumor cells in the bone marrow.
    Schindlbeck C; Janni W; Shabani N; Rack B; Gerber B; Schmitt M; Harbeck N; Sommer H; Braun S; Friese K
    Breast Cancer Res Treat; 2004 Sep; 87(1):65-74. PubMed ID: 15377852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.
    Naume B; Borgen E; Beiske K; Herstad TK; Ravnås G; Renolen A; Trachsel S; Thrane-Steen K; Funderud S; Kvalheim G
    J Hematother; 1997 Apr; 6(2):103-14. PubMed ID: 9131439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIalpha-status of the primary tumor?
    Schindlbeck C; Janni W; Shabani N; Kornmeier A; Rack B; Rjosk D; Gerber B; Braun S; Sommer H; Friese K
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):539-46. PubMed ID: 15887027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase.
    Borgen E; Beiske K; Trachsel S; Nesland JM; Kvalheim G; Herstad TK; Schlichting E; Qvist H; Naume B
    J Pathol; 1998 Aug; 185(4):427-34. PubMed ID: 9828843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications.
    Funaki S; Sawabata N; Nakagiri T; Shintani Y; Inoue M; Kadota Y; Minami M; Okumura M
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):322-7. PubMed ID: 21215651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
    Harbeck N; Untch M; Pache L; Eiermann W
    Br J Cancer; 1994 Mar; 69(3):566-71. PubMed ID: 7510120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer.
    Wiedswang G; Borgen E; Schirmer C; Kåresen R; Kvalheim G; Nesland JM; Naume B
    Int J Cancer; 2006 Apr; 118(8):2013-9. PubMed ID: 16287086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.
    Borgen E; Naume B; Nesland JM; Kvalheim G; Beiske K; Fodstad O; Diel I; Solomayer EF; Theocharous P; Coombes RC; Smith BM; Wunder E; Marolleau JP; Garcia J; Pantel K
    Cytotherapy; 1999; 1(5):377-88. PubMed ID: 20426539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
    Rack B; Jückstock J; Genss EM; Schoberth A; Schindlbeck C; Strobl B; Heinrigs M; Rammel G; Zwingers T; Sommer H; Friese K; Janni W
    Anticancer Res; 2010 May; 30(5):1807-13. PubMed ID: 20592383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
    Braun S; Pantel K; Müller P; Janni W; Hepp F; Kentenich CR; Gastroph S; Wischnik A; Dimpfl T; Kindermann G; Riethmüller G; Schlimok G
    N Engl J Med; 2000 Feb; 342(8):525-33. PubMed ID: 10684910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DTCs in breast cancer: clinical research and practice.
    Janni W; Rack B; Kasprowicz N; Scholz C; Hepp P
    Recent Results Cancer Res; 2012; 195():173-8. PubMed ID: 22527504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
    Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
    J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rating of isolated disseminated tumor cells in bone marrow in comparison with other factors of prognosis in breast carcinoma.
    Leinung S; Würl P; Schönfelder A; Weiss CL; Röder I; Schönfelder M
    Int J Surg Investig; 2000; 2(3):193-202. PubMed ID: 12678519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.